Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 109

Sort by

Sort Order Select

Journal Articles

Mogamulizumab within 55 Days of Allogeneic Transplant: A Report of 3 Cases

Mary Jo Lechowicz, MD, Dolores Caballero, MD PhD, Mollie Leoni, MD, Marilyn Tabachri, RN, BSN, Fiona Herr, PhD, Zanetta S. Lamar, MD

Blood (2019) 134 (Supplement_1): 5297.

https://doi.org/10.1182/blood-2019-129302

Published: 2019

Journal Articles

Identification of Targetable Tumor Associated Proteins in Adult T-Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL) Including a Novel CC-Chemokine 4 (CCR4)-Positive T-ALL/LBL with Unique Immunophenotype

Sharad Khurana, MDMSc, Michael G. Heckman, Jordan Cochuyt, Fiona E. Craig, MBBS, Zaid Abdel Rahman, MD, Patricia Greipp, DO, Lisa Z. Sproat, MD, Mark Litzow, MD, James M. Foran, MD, Liuyan Jiang

Blood (2019) 134 (Supplement_1): 5210.

https://doi.org/10.1182/blood-2019-123286

Published: 2019

Journal Articles

Novel Immunotherapeutic Approaches for Hodgkin Lymphoma

Barbara Savoldo, MD PhD, Natalie S Grover, MD, Carlos A. Ramos, MD, Gianpietro Dotti, MD

Blood (2019) 134 (Supplement_1): SCI-9.

https://doi.org/10.1182/blood-2019-121075

Published: 2019

Journal Articles

Long-Term Clinical Benefit to Anti-CCR4 Mogamulizumab: Results from the Phase 3 Mavoric Study in Previously Treated Cutaneous T-Cell Lymphoma (CTCL)

Martine Bagot, MD PhD, Stéphane Dalle, MD PhD, Lubomir Sokol, MD PhD, Athanasios Tsianakas, MD, Amy Musiek, MD, Pablo Ortiz-Romero, MD, Brian Poligone, MD PhD, Madeleine Duvic, MD, Craig Elmets, MD, Mollie Leoni, MD, Karen Dwyer, Wei Sun, PhD, Elena Nikonova, MD, Youn H. Kim, MD

Blood (2018) 132 (Supplement 1): 2901.

https://doi.org/10.1182/blood-2018-99-118473

Published: 2018

Journal Articles

CCR2 + Monocyte-Derived Ly6C - F4/80 + Fibrocytes Inhibit Collagen Degradation and Contribute to the Development of Colon Fibrosis Via Production of TIMP-1

Masahiro Masuya, MD PhD, Naoki Kuroda, MD, Kensuke Hachiya, MD, Isao Tawara, MD PhD, Yuki Kageyama, MD, Kohshi Ohishi, MD PhD, Hiroshi Miwa, MD PhD, Naoyuki Katayama, MD PhD

Blood (2018) 132 (Supplement 1): 3682.

https://doi.org/10.1182/blood-2018-99-118140

Published: 2018

Journal Articles

HIF-2α Upregulates CCR1 to Promote Dissemination of Plasma Cells in Multiple Myeloma

Mara N Zeissig, BSc, Duncan R. Hewett, BA (Hons), PhD, Sally Martin, PhD, Krzysztof M Mrozik, BSc, Chee Man Cheong, PhD, Peter Diamond, PhD, Luen Bik To, MBBS, FRACP, FRCPA, PhD, Stan Gronthos, PhD, Daniel J Peet, PhD, Peter I Croucher, BSc, PhD, Kate Vandyke, PhD, Andrew C. W. Zannettino, BSc (Hons), PhD

Blood (2017) 130 (Supplement 1): 4425.

https://doi.org/10.1182/blood.V130.Suppl_1.4425.4425

Published: 2017

Journal Articles

Mogamulizumab Monotherapy in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma or Cutaneous T-Cell Lymphoma Patients in Single-Institution Experience

Kazunori Murai, MD PhD, Hamada Hiroyuki, MD, Akiyoshi Sato, MD ,PhD, Miyairi Yasuro, MD, PhD, Yasuki Mori, MD,PhD, Tsutomu Sakuma, MD, PhD

Blood (2017) 130 (Supplement 1): 5179.

https://doi.org/10.1182/blood.V130.Suppl_1.5179.5179

Published: 2017

Journal Articles

The Anti-Viral Compound Cosalane Attenuates Acute Graft-Versus-Host Disease in Murine Hematopoietic Stem Cell Transplant Models

Kenneth A. Fowler, MS, Danny W. Bruce, PhD, James M. Coghill, Jr., MD

Blood (2017) 130 (Supplement 1): 3178.

https://doi.org/10.1182/blood.V130.Suppl_1.3178.3178

Published: 2017

Journal Articles

Proof of Merit in New Diet Therapy Against Adult T-Cell Leukemia/Lymphoma: Applying Specific Amino Acid Dependency of Leukemia/Lymphoma Cells

Tomohiro Ishigaki, MD PhD, Yuki Taya, MD PhD, Satoshi Yamazaki, PhD, Seiichiro Kobayashi, MD PhD, Nobuhiro Ohno, MD, Kaoru Uchimaru, MD PhD, Arinobu Tojo, MD PhD, Hiromitsu Nakauchi, MD PhD

Blood (2016) 128 (22): 1765.

https://doi.org/10.1182/blood.V128.22.1765.1765

Published: 2016

Journal Articles

A Prospective, Multicenter, Randomized Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Investigator's Choice in the Treatment of Patients with Relapsed/Refractory Adult T-Cell Leukemia-Lymphoma: Overall Response Rate, Progression-Free Survival, and Overall Survival

Blood (2016) 128 (22): 4159.

https://doi.org/10.1182/blood.V128.22.4159.4159

Published: 2016

Journal Articles

Mogamulizumab Therapy for Adult T-Cell Leukemia-Lymphoma: A Retrospective Multicenter Study

Blood (2015) 126 (23): 2703.

https://doi.org/10.1182/blood.V126.23.2703.2703

Published: 2015

Journal Articles

CCL-2 Is a KIT D816V-Dependent Modulator of Bone Marrow Remodeling and Microenvironmental Alterations in Systemic Mastocytosis

Georg Greiner, MD, Nadine Witzeneder, Klaus Schmetterer, MD PhD, Theresia Popow-Kraupp, MD, Wolfgang R Sperr, MD, Peter Valent, MD, Matthias Mayerhofer, MD, Gregor Hoermann, MD PhD

Blood (2015) 126 (23): 1635.

https://doi.org/10.1182/blood.V126.23.1635.1635

Published: 2015

Journal Articles

B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment

Roel Polak, Bob de Rooij, Rob Pieters, Monique L. den Boer

Blood (2015) 126 (21): 2404–2414.

https://doi.org/10.1182/blood-2015-03-634238

Published: 2015

Includes: Multimedia, Supplemental data

Journal Articles

Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia

Valentina Audrito, Sara Serra, Davide Brusa, Francesca Mazzola, Francesca Arruga, Tiziana Vaisitti, Marta Coscia, Rossana Maffei, Davide Rossi, Tao Wang, Giorgio Inghirami, Menico Rizzi, Gianluca Gaidano, Joe G. N. Garcia, Cynthia Wolberger, Nadia Raffaelli, Silvia Deaglio

Blood (2015) 125 (1): 111–123.

https://doi.org/10.1182/blood-2014-07-589069

Published: 2015

Includes: Supplemental data

Journal Articles

Early Homeostatic Expansion of Regulatory T Cells with the Predominant Effector/Memory Phenotype May Stabilize Immune Recovery in the First Month after HSCT

Takanori Yoshioka, MD, Yusuke Meguri, MD, Takeru Asano, MD, Taro Masunari, MD PhD, Kumiko Kagawa, MD PhD, Koichi Nakase, MD PhD, Yoshinobu Maeda, MD PhD, Mitsune Tanimoto, MD PhD, Ken-ichi Matsuoka, MD PhD

Blood (2014) 124 (21): 2501.

https://doi.org/10.1182/blood.V124.21.2501.2501

Published: 2014

Journal Articles

A Gain-of-Function CCR4 Mutations in Adult T-Cell Leukemia/Lymphoma (ATLL) Enhance the Chemotactic Abilities and PI3K/AKT Activation

Masao Nakagawa, MD PhD, Roland Schmitz, PhD, Wenming Xiao, Carolyn K Goldman, Weihong Xu, Yandan Yang, PhD, Thomas A Waldmann, MD, Louis M. Staudt, MD PhD

Blood (2014) 124 (21): 3566.

https://doi.org/10.1182/blood.V124.21.3566.3566

Published: 2014

Journal Articles

Determination of the Microbicidal Capacity of Platelets By a Biomonitoring System

Volker R. Stoldt, PhD, Rudiger E. Scharf, MD FAHA

Blood (2014) 124 (21): 4993.

https://doi.org/10.1182/blood.V124.21.4993.4993

Published: 2014

Journal Articles

Concomitant Administration of Gene-Modified T Cells Expressing a Chimeric CD16-CD3ζ Receptor with Mogamulizmab Synergistically Suppresses Adult T Cell Leukemia Cells in Vivo

Kazushi Tanimoto, MD PhD, Hiroshi Fujiwara, MD PhD, Hiroki Tanaka, MD, Fumihiro Ochi, MD, Hiroaki Asai, MDPhD, Sachiko Okamoto, PhD, Junichi Mineno, PhD, Kiyotaka Kuzushima, MD PhD, Hiroshi Shiku, MD PhD, John Barrett, MD, Masaki Yasukawa, MD PhD

Blood (2014) 124 (21): 307.

https://doi.org/10.1182/blood.V124.21.307.307

Published: 2014

Journal Articles

TGF-Beta Signaling Favors Central Memory Phenotype Expression By Ex-Vivo Stimulated Human T Cells

Amina Dahmani, Cédric Carli, PhD, Julie Taillefer, Mathieu Goupil, Myriam Khalili, Jean-Sebastien Delisle, MD PhD

Blood (2014) 124 (21): 3841.

https://doi.org/10.1182/blood.V124.21.3841.3841

Published: 2014

Journal Articles

CCL8 Deficiency in Host Strongly Inhibits Early Mortality and Morbidity of Graft-Versus-Host Disease in Mice

Keita Igarashi, MD, Norio Takei, PhD, Tsukasa Hori, MD PhD, Masaki Yamamoto, MD PhD, Yasuo Kokai, MD PhD

Blood (2014) 124 (21): 1096.

https://doi.org/10.1182/blood.V124.21.1096.1096

Published: 2014

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Mogamulizumab within 55 Days of Allogeneic Transplant: A Report of 3 Cases

Identification of Targetable Tumor Associated Proteins in Adult T-Acute Lymphoblastic Leukemia/Lymphoma (T-ALL/LBL) Including a Novel CC-Chemokine 4 (CCR4)-Positive T-ALL/LBL with Unique Immunophenotype

Novel Immunotherapeutic Approaches for Hodgkin Lymphoma

Long-Term Clinical Benefit to Anti-CCR4 Mogamulizumab: Results from the Phase 3 Mavoric Study in Previously Treated Cutaneous T-Cell Lymphoma (CTCL)

CCR2 + Monocyte-Derived Ly6C - F4/80 + Fibrocytes Inhibit Collagen Degradation and Contribute to the Development of Colon Fibrosis Via Production of TIMP-1

HIF-2α Upregulates CCR1 to Promote Dissemination of Plasma Cells in Multiple Myeloma

Mogamulizumab Monotherapy in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma or Cutaneous T-Cell Lymphoma Patients in Single-Institution Experience

The Anti-Viral Compound Cosalane Attenuates Acute Graft-Versus-Host Disease in Murine Hematopoietic Stem Cell Transplant Models

Proof of Merit in New Diet Therapy Against Adult T-Cell Leukemia/Lymphoma: Applying Specific Amino Acid Dependency of Leukemia/Lymphoma Cells

A Prospective, Multicenter, Randomized Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Investigator's Choice in the Treatment of Patients with Relapsed/Refractory Adult T-Cell Leukemia-Lymphoma: Overall Response Rate, Progression-Free Survival, and Overall Survival

Mogamulizumab Therapy for Adult T-Cell Leukemia-Lymphoma: A Retrospective Multicenter Study

CCL-2 Is a KIT D816V-Dependent Modulator of Bone Marrow Remodeling and Microenvironmental Alterations in Systemic Mastocytosis

B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment

Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia

Early Homeostatic Expansion of Regulatory T Cells with the Predominant Effector/Memory Phenotype May Stabilize Immune Recovery in the First Month after HSCT

A Gain-of-Function CCR4 Mutations in Adult T-Cell Leukemia/Lymphoma (ATLL) Enhance the Chemotactic Abilities and PI3K/AKT Activation

Determination of the Microbicidal Capacity of Platelets By a Biomonitoring System

Concomitant Administration of Gene-Modified T Cells Expressing a Chimeric CD16-CD3ζ Receptor with Mogamulizmab Synergistically Suppresses Adult T Cell Leukemia Cells in Vivo

TGF-Beta Signaling Favors Central Memory Phenotype Expression By Ex-Vivo Stimulated Human T Cells

CCL8 Deficiency in Host Strongly Inhibits Early Mortality and Morbidity of Graft-Versus-Host Disease in Mice

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only